The startup develops DNA sequencing technology that utilizes silicon-based detection and enzyme-based sequencing chemistry to reduce sample preparation and reagent usage. By offloading computational tasks to the cloud, the company provides a faster and more cost-effective genome sequencing solution for clients.
Funding
$530K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current next-generation sequencing (NGS) platforms often involve lengthy turnaround times and high costs due to complex sample preparation and reagent requirements. These factors can limit accessibility and increase the overall expense of genomic analysis.
Solution
Stream Genomics is developing a novel NGS platform designed to significantly reduce sequencing time and cost. The platform utilizes advancements in both silicon-based detection and enzyme-based sequencing chemistry to streamline the workflow. By optimizing these core components, Stream Genomics aims to provide a faster and more accessible solution for a wide range of sequencing applications, potentially cutting sequencing time from days to minutes.
Target Audience
The primary target audience includes researchers, clinical laboratories, and other organizations requiring rapid and cost-effective DNA sequencing.
Features
- Silicon-based detection system for rapid signal acquisition.
- Enzyme-based sequencing chemistry to minimize reagent consumption.
- Streamlined workflow reducing the number of steps required for sample preparation.
- Low-cost platform designed for accessibility at any scale.